Yancopoulos, MD, PhD, Board Co-Chair, President and Chief Scientific Officer at Regeneron, said the results highlight both the efficacy and tolerability potential of the therapy in obesity treatment
Yes, GLP-1 medications can cause fatigue in some patients, though severity and timing vary significantly
Kaufman, MD Distinguished Professor Emeritus Childrens Hospital Los Angeles/Senseonics Website: Expertise: Dr
The income statement showed that variable and fixed costs were as planned, which meant that the 2014 annual net income projection would not be met unless management took action
Anita Blanton: And I see any time there is a lawsuit against a major corporation, if its successful, we often hear about what people get in return, and sometimes its very little once it gets to that class action level